Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon

Sexually Transmitted Diseases

Volumn 27, Issue 3, 2000, Pages 159-164

  Rezza, Giovanni ^a   Tchangmena, Odile Befeuka ^a   Andreoni, Massimo ^b   Bugarini, Roberto ^a   Toma, Luigi ^a   Bakary, Djibrilla Kaou ^c   Glikoutou, Michel ^c   Sarmati, Loredana ^c   Monini, Paolo ^a   Pezzotti, Patrizio ^a   Ensoli, Barbara ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; CAMEROON; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN HERPESVIRUS 8; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEROCONVERSION; SEXUAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 17644439870     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200003000-00008     Document Type: Article

References (24)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
2. Gao S-J, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2:925-928.
3. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2:918-924.
4. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348:858-861.
5. Rezza G, Lennette ET, Giuliani M, et al. Prevalence and determinants' of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 1998; 77:361-365.
6. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi's sarcoma-associated virus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 1997; 277:478-481.
7. Blauvelt A, Sei S, Cook P, Schulz TF, Jeang K-T. Human herpesvirus 8 infection occurs following adolescence in the United States. J Infect Dis 1997; 176:771-774.
8. Monini P, De Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996; 334:1168-1172.
9. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338:948-954.
10. Olsen SJ, Chang Y, Moore PS, Biggar RJ, Melbye M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 1998; 12:1921-1925.
11. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77:817-820.
12. Andreoni M, El-Sawaf G, Rezza G, et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of non-sexual transmission. J Natl Cancer Inst 1999; 91:465-469.
13. Gessain A, Mauclère P, Van Beveren M, et al. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999; 81:189-192.
14. Jensen OM, Tuyns AJ, Ravisse P. Cancer in Cameroon: a relative frequency study. Rev Epidemiol Sante Pub 1978; 26:147-159.
15. Monini P, Carlini F, Sturzl M, et al. α-interferon inhibits HHV-8 reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol 1999; 75:4029-4041.
16. Angeloni A, Heston L, Uccini S, et al. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 1998; 177:1715-1718.
17. Hutt MSR. Kaposi's sarcoma. Br Med Bull 1984; 40: 355-358.
18. Mbakop A, Oyono JLE, Ngbangako MC, Abondo A. Epidemiologie actuelle des cancers au Cameroon (Afrique Centrale). Bull Cancer 1992; 79:1101-1104.
19. Arijoshi K, Schim van der Loeff M, Cook P, et al. Kaposi's sarcoma in the Gambia, West Africa, is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998; 1:193-199.
20. He J, Bhat G, Kankasa C, et al. Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J Infect Dis 1998; 178:1787-1790.
21. Bestetti G, Renon G, Mauclére P, et al. High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 1998; 12:541-542.
22. Ziegler JL, Newton R, Katongole-Mbidde E, et al. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS 1997; 11:1619-1626.
23. Mouden JC, Durand JP, Garrigue JP. Le lymphomae de Burkitt au Cameroun. Bull Soc Path Exot 1988; 81:15-23.
24. Rezza G, Andreoni M, Dorrucci M, et al. Human herpesvirus-8 seropositivity and risk of developing Kaposi's sarcoma and other AIDS-related diseases among individuals with known dates of HIV seroconversion. J Natl Cancer Inst 2000 (in press).